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Abstract
Background: The adrenals are known as an important link in pathogenesis of arterial hypertensive disease. The
study was directed to the adrenal transcriptome analysis in ISIAH rats with stress-sensitive arterial hypertension and
predominant involvement in pathogenesis of the hypothalamic-pituitary-adrenal and sympathoadrenal systems.
Results: The RNA-Seq approach was used to perform the comparative adrenal transcriptome profiling in
hypertensive ISIAH and normotensive WAG rats. Multiple differentially expressed genes (DEGs) related to different
biological processes and metabolic pathways were detected.
The discussion of the results helped to prioritize the several DEGs as the promising candidates for further studies of
the genetic background underlying the stress-sensitive hypertension development in the ISIAH rats. Two of these
were transcription factor genes (Nr4a3 and Ppard), which may be related to the predominant activation of the
sympathetic-adrenal medullary axis in ISIAH rats. The other genes are known as associated with hypertension and
were defined in the current study as DEGs making the most significant contribution to the inter-strain differences.
Four of them (Avpr1a, Hsd11b2, Agt, Ephx2) may provoke the hypertension development, and Mpo may contribute
to insulin resistance and inflammation in the ISIAH rats.
Conclusions: The study strongly highlighted the complex nature of the pathogenesis of stress-sensitive
hypertension. The data obtained may be useful for identifying the common molecular determinants in different
animal models of arterial hypertension, which may be potentially used as therapeutic targets for pharmacological
intervention.
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Background
The adrenal gland is known as a key organ playing an
important role in the blood pressure regulation and
hypertension development. The adrenal gland produces
corticosteroid hormones and catecholamines that regu-
late a complex set of vital organismic functions includ-
ing the stress control, water and sodium balance,
cardiovascular system and the blood pressure (BP) level
[1, 2]. That’s why the adrenal gland is an object of choice
in a number of studies directed to elucidate the complex
nature of hypertensive disease development or neuroen-
docrine profile related to stress response [3–5].
Different animal models of arterial hypertension help
to analyze the transcriptome of the adrenal glands and
to uncover common genetic mechanisms of hyperten-
sion across mammalian species that might, therefore, be
pertinent to human hypertension too [3, 4, 6].
The ISIAH rat strain is a model of stress-sensitive ar-
terial hypertension with predominant involvement of the
neuroendocrine hypothalamic-pituitary-adrenocortical
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(HPA) and sympathetic adrenal systems (SAS) in patho-
genesis of hypertension [7–9]. The peripheral plasma al-
dosterone concentration and secretion rates of
corticosterone, 11-dehydrocorticosterone and deoxycor-
ticosterone measured by the adrenal vein cannulation
were significantly higher in the ISIAH rats as compared
to control WAG rats [10]. The sympathetic adrenal me-
dullary function assessed by measurement of the adrenal
catecholamine content showed decreased concentrations
of dopamine and norepinephrine, but significantly en-
hanced level of epinephrine in the adrenals of ISIAH rats
[9]. It was suggested that the genetically determined en-
hanced stress responsiveness and hypertension develop-
ment in ISIAH rats may be a result of the specificity of
its adrenal gland function [10].
The differences in the transcription activity of several
genes measured in the adrenal glands of hypertensive
ISIAH and control WAG rats [9, 10] demonstrated that
the selection of the ISIAH rat strain for the enhanced re-
sponsiveness to mild emotional stress could lead to ac-
cumulation of the genetic changes which may affect the
hypertension development.
The goal of the current study was to compare the full
transcriptome profiles of the adrenal glands from hyper-
tensive ISIAH and normotensive WAG rats in order to
identify the main pathways involved in the differences of
their adrenal gland functions, and to define the differen-
tially expressed genes (DEGs) which could make the lar-
gest contribution to the stress-sensitive hypertension
development.
The current study of the comparative transcriptome
profiling of the adrenal glands in hypertensive ISIAH
and control WAG rats resulted in the detection of mul-
tiple DEGs related to different biological processes and
metabolic pathways. The use of the partial-least squares
discriminant analysis (PLS-DA) helped to reveal the top
10 DEGs associated with hypertension and making the
most significant contribution to the inter-strain differ-
ences. Several of these DEGs may be considered as po-
tential candidates for further studies directed to better
understanding the mechanisms of hypertension develop-
ment in the ISIAH rats.
Results
Altogether, 12367 genes were defined as expressed in ad-
renal glands of ISIAH and WAG rats and were used in
comparative expression analysis, which revealed 1113
DEGs. The complete listing of DEGs is given in Add-
itional file 1. The hierarchical clustering based on Eu-
clidean distance is shown in Additional file 2. More than
half of the DEGs (619 genes, i.e., 55.6%) were upregu-
lated in ISIAH rats.
The expression of 19 genes was detected in adrenal
gland of only one rat strain (Additional file 3). Three of
these genes (Crp, C-reactive protein, pentraxin-related;
Fabp1, fatty acid binding protein 1, liver; Ucp1, uncoup-
ling protein 1 (mitochondrial, proton carrier)) are known
as related to hypertension development. Their expres-
sion was detected in adrenal gland of ISIAH rats but not
in the WAG.
Altogether, the study revealed 76 DEGs annotated in
Rat Genome Database (RGD) as related to hypertension
(Table 1). Most of these genes (71.1%) were upregulated
in hypertensive adrenal glands. Twenty three genes of
those listed in Table 1 are known as associated with in-
sulin resistance. Almost all of them (20 out of 23 genes)
were upregulated in adrenals from ISIAH rats.
Many of DEGs (166 genes) found in the current study
are known as related to the metabolic diseases including
hypercholesterolemia, hyperglycemia, hyperlipidemia,
different types of hyperlipoproteinemias, and insulin re-
sistance (Table 2).
Sixty one transcription factor genes were differentially
expressed in ISIAH and WAG adrenal glands (Table 3).
Three of them are currently known as associated with
hypertension development and 8 genes are referred to in
RGD as related to metabolic diseases.
Gene Ontology (GO) terms for biological processes
found to be significantly enriched are represented in
Additional file 4. The groups of DEGs, which might be
important for the development of the stress-sensitive
hypertension, are given in bold in the file. The main
groups are given in Fig. 1. The subgroups describing the
specificity of the processes shown in Fig. 1 are repre-
sented in Additional file 5. The detailed information for
genes in these groups is given in Additional file 6.
The most abundant group described by GO term ‘re-
sponse to stimulus’ consisted of groups related to re-
sponse to different stimuli - external stimulus,
endogenous (hormone) stimulus, and stress, which were
found to be among the most significantly enriched GO
terms. The group of DEGs labelled ‘response to hor-
mone stimulus’, consisted of subgroups of DEGs related
to response to steroid hormone stimulus (and particu-
larly to corticosteroid stimulus), response to growth hor-
mone, and insulin stimuli. The response to stress was
specified by the group of genes related to response to
oxygen levels. Almost all genes (25 out of 27) in this
group were related to response to hypoxia.
Several groups of DEGs related to BP control were
found. These were: regulation of body fluid levels, blood
circulation, blood coagulation, regulation of BP, regula-
tion of angiogenesis and blood vessel size, regulation of
smooth muscle cell proliferation and contraction.
Several other processes, which may play an important
role in stress-sensitive hypertension development in
ISIAH rats were: regulation of catecholamine secretion,
glucose homeostasis, regulation of insulin-like growth
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Table 1 Genes differentially expressed in ISIAH and WAG adrenal glands and referred to in Rat Genome Database as associated with
hypertension
Gene symbol Gene_ID log2
(fold_change) ISIAH/WAG
Gene definition
Ada 24165 0.75 adenosine deaminase
Adipoqa 246253 1.10 adiponectin, C1Q and collagen
domain containing
Adrb3a 25645 2.44 adrenergic, beta-3-, receptor
Agta 24179 2.28 angiotensinogen (serpin peptidase
inhibitor, clade A, member 8)
Alas1 65155 0.75 aminolevulinate, delta-, synthase 1
Alox5 25290 −0.83 arachidonate 5-lipoxygenase
Anxa3 25291 0.69 annexin A3
Aqp1 25240 −0.49 aquaporin 1
Atp1a2a 24212 1.26 ATPase, Na+/K+ transporting, alpha 2
polypeptide
Avpr1a 25107 1.12 arginine vasopressin receptor 1A
Bchea 65036 1.32 butyrylcholinesterase
C1qb 29687 0.61 complement component 1, q
subcomponent, B chain
C3a 24232 2.06 complement component 3
Cd36a 29184 1.04 CD36 molecule (thrombospondin receptor)
Cdkn2b 25164 −0.85 cyclin-dependent kinase inhibitor 2B
(p15, inhibits CDK4)
Cdo1 81718 −1.20 cysteine dioxygenase, type I
Cfh 155012 0.76 complement factor H
Col1a1 29393 0.80 collagen, type I, alpha 1
Crpa 25419 detected only in ISIAH rats C-reactive protein, pentraxin-related
Cx3cr1 171056 0.75 chemokine (C-X3-C motif) receptor 1
Cxcl10 245920 −1.90 chemokine (C-X-C motif) ligand 10
Cybaa 79129 0.68 cytochrome b-245, alpha polypeptide
Dusp1 114856 −0.94 dual specificity phosphatase 1
Ednrb 50672 0.82 endothelin receptor type B
Egr1 24330 −0.92 early growth response 1
Entpd2 64467 0.84 ectonucleoside triphosphate
diphosphohydrolase 2
Ephx2a 65030 4.37 epoxide hydrolase 2, cytoplasmic
F2r 25439 0.53 coagulation factor II (thrombin receptor
F5 304929 0.62 coagulation factor V (proaccelerin, labile factor)
Fabp1 24360 detected only in ISIAH rats fatty acid binding protein 1, liver
Fas 246097 −0.80 Fas (TNF receptor superfamily, member 6)
Fbn1 83727 0.69 fibrillin 1
Fmo3 84493 0.57 flavin containing monooxygenase 3
Fn1 25661 0.76 fibronectin 1
Gabbr1 81657 1.11 gamma-aminobutyric acid (GABA) B receptor 1
Gstm2 24424 −0.60 glutathione S-transferase mu 2
Gstp1 24426 −0.53 glutathione S-transferase pi 1
Hdac4 363287 0.73 histone deacetylase 4
Hmgb1 25459 −0.84 high mobility group box 1
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Table 1 Genes differentially expressed in ISIAH and WAG adrenal glands and referred to in Rat Genome Database as associated with
hypertension (Continued)
Hmgcra 25675 0.63 3-hydroxy-3-methylglutaryl-CoA
reductase
Hmox1a 24451 −0.69 heme oxygenase (decycling) 1
Hpa 24464 1.10 haptoglobin
Hsd11b2 25117 −1.47 hydroxysteroid 11-beta dehydrogenase 2
Hyal1 367166 0.49 hyaluronoglucosaminidase 1
Igf1 24482 −2.12 insulin-like growth factor 1
Itgava 296456 −0.58 integrin, alpha V
Loxl1 315714 0.50 lysyl oxidase-like 1
Lpla 24539 0.52 lipoprotein lipase
Mpo 303413 4.46 myeloperoxidase
Nov 81526 −0.88 nephroblastoma overexpressed gene
Pik3r1a 25513 0.50 phosphoinositide-3-kinase, regulatory
subunit 1 (alpha)
Postn 361945 1.30 periostin, osteoblast specific factor
Pparga 25664 1.01 peroxisome proliferator-activated
receptor gamma
Prkcba 25023 0.90 protein kinase C, beta
Retna 246250 2.26 resistin
Rgs5 54294 −0.85 regulator of G-protein signaling 5
RT1-Ba 309621 0.49 RT1 class II, locus Ba
RT1-Db1 294270 0.91 RT1 class II, locus Db1
S100b 25742 −1.72 S100 calcium binding protein B
Serpina1a 24648 0.77 serpin peptidase inhibitor, clade A
(alpha-1 antiproteinase, antitrypsin, member 1
Serpine1a 24617 −2.04 serpin peptidase inhibitor, clade E
(nexin, plasminogen activator
inhibitor type 1), member 1
Serpine2 29366 2.19 serpin peptidase inhibitor,
clade E, member 2
Slc4a4 84484 0.96 solute carrier family 4, sodium bicarbonate
cotransporter, member 4
Slc8a1 29715 0.58 solute carrier family 8 (sodium/calcium
exchanger), member 1
Slc9a3 24784 4.24 solute carrier family 9 (sodium/hydrogen
exchanger), member 3
Sod2 24787 0.75 superoxide dismutase 2, mitochondrial
Spp1 25353 −0.56 secreted phosphoprotein 1
Tacr2 25007 0.84 tachykinin receptor 2
Tap1 24811 0.84 transporter 1, ATP-binding cassette, sub-family B (MDR/TAP)
Tek 89804 0.49 TEK tyrosine kinase, endothelial
Tnc 116640 1.74 tenascin C
Trpc6 89823 0.85 transient receptor potential cation channel, subfamily C, member 6
Ucp1a 24860 detected only in ISIAH rats uncoupling protein 1 (mitochondrial, proton carrier)
Vcam1a 25361 0.78 vascular cell adhesion molecule 1
Vip 117064 −1.57 vasoactive intestinal peptide
Xdh 497811 −0.88 xanthine dehydrogenase
a- genes associated with insulin resistance; ISIAH and WAG – rat strains used in the study
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Table 2 Genes differentially expressed in ISIAH and WAG adrenal glands and referred to in Rat Genome Database as associated with
metabolic diseases
Gene symbol Gene_ID log2
(fold_change) ISIAH/WAG
Gene definition
Abca1a b d e 313210 1.12 ATP-binding cassette, subfamily A
(ABC1), member 1
Abcg2 312382 1.09 ATP-binding cassette, subfamily G
(WHITE), member 2
Acacba 116719 0.98 acetyl-CoA carboxylase beta
Acad9 294973 0.63 acyl-CoA dehydrogenase family, member 9
Acadsb 25618 −0.71 acyl-CoA dehydrogenase, short/branched chain
Acot2 192272 −0.55 acyl-CoA thioesterase 2)
Acp5 25732 −1.54 acid phosphatase 5, tartrate resistant
Ada c 24165 0.75 adenosine deaminase
Adipoqa d 246253 1.10 adiponectin, C1Q and collagen
domain containing
Adrb3a 25645 2.44 adrenergic, beta-3-, receptor
Adssl1 684425 0.91 adenylosuccinate synthase like 1
Agta 24179 2.28 angiotensinogen (serpin peptidase
inhibitor, clade A, member 8)
Ahsga d 25373 detected only in ISIAH rats alpha-2-HS-glycoprotein
Aif1 29427 0.95 allograft inflammatory factor 1
Ak1 24183 −0.72 adenylate kinase 1
Alas1 65155 0.75 aminolevulinate, delta-, synthase 1
Alpla b d 25586 −1.32 alkaline phosphatase, liver/bone/kidney
Anxa5 25673 −0.97 annexin A5
Aox1 54349 1.74 aldehyde oxidase 1
Apoc1d 25292 −0.90 apolipoprotein C-I
Aqp1 25240 −0.49 aquaporin 1
Arsb 25227 −0.49 arylsulfatase B
Aspa 79251 1.01 aspartoacylase
Atp1a2a 24212 1.26 ATPase, Na+/K+ transporting,
alpha 2 polypeptide
Bchea d 65036 1.32 butyrylcholinesterase
C1qa 298566 0.77 complement component 1, q
subcomponent, A chain
C3a 24232 2.06 complement component 3
Cartpt 29131 −3.09 CART prepropeptide
Casq1 686019 −1.87 calsequestrin 1 (fast-twitch, skeletal muscle)
Casq2 29209 2.32 calsequestrin 2 (cardiac muscle)
Ccl11c 29397 1.41 chemokine (C-C motif) ligand 11
Cd36a 29184 1.04 CD36 molecule (thrombospondin receptor)
Cfb 294257 0.65 complement factor B
Cfh 155012 0.76 complement factor H
Chek2a 114212 −0.92 checkpoint kinase 2
Cidec 500292 1.65 cell death-inducing DFFA-like effector c
Col1a1 29393 0.80 collagen, type I, alpha 1
Cpox 304024 0.50 coproporphyrinogen oxidase
Crpa d 25419 detected only in ISIAH rats C-reactive protein, pentraxin-related
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Table 2 Genes differentially expressed in ISIAH and WAG adrenal glands and referred to in Rat Genome Database as associated with
metabolic diseases (Continued)
Cx3cr1 171056 0.75 chemokine (C-X3-C motif) receptor 1
Cxcl10 245920 −1.90 chemokine (C-X-C motif) ligand 10
Cxcl12 24772 0.91 chemokine (C-X-C motif) ligand 12
Cybaa 79129 0.68 cytochrome b-245, alpha polypeptide
Cyp2e1 25086 1.91 cytochrome P450, family 2, subfamily
e, polypeptide 1
Dab2 79128 0.79 disabled homolog 2 (Drosophila)
Dcaf12l1 313296 −1.59 DDB1 and CUL4 associated factor 12-like 1
Dcn 29139 0.54 decorin
Dgat1a d 84497 0.63 diacylglycerol O-acyltransferase 1
Dusp1c 114856 −0.94 dual specificity phosphatase 1
Ednrb 50672 0.82 endothelin receptor type B
Ehhadh 171142 2.01 enoyl-CoA, hydratase/3-hydroxyacyl
CoA dehydrogenase
Entpd5 314312 −1.00 ectonucleoside triphosphate
diphosphohydrolase 5
Ephx2a b d e 65030 4.37 epoxide hydrolase 2, cytoplasmic
Ercc4 304719 −1.12 excision repair cross-complementing rodent repair
deficiency, complementation group 4
F13a1 60327 1.00 coagulation factor XIII, A1 polypeptide
Fabp4a 79451 1.61 fatty acid binding protein 4, adipocyte
Fam111a 499322 3.85 family with sequence similarity 111, member A
Fam126a 499975 −0.72 family with sequence similarity 126, member A
Fas 246097 −0.80 Fas (TNF receptor superfamily, member 6)
Fbn1 83727 0.69 fibrillin 1
Fgb 24366 detected only in ISIAH rats fibrinogen beta chain
Fgg 24367 1.47 fibrinogen gamma chain
Fmo3 84493 0.57 flavin containing monooxygenase 3
Fn1 25661 0.76 fibronectin 1
Foxo1a 84482 −0.86 forkhead box O1
Fus 317385 0.65 fused in sarcoma
Gabbr1 81657 1.11 gamma-aminobutyric acid (GABA) B receptor 1
Galns 292073 0.81 galactosamine (N-acetyl)-6-sulfate sulfatase
Gas6 58935 0.50 growth arrest specific 6
Gatm 81660 −1.26 glycine amidinotransferase
(L-arginine:glycine amidinotransferase)
Gcgr 24953 1.02 glucagon receptor
Gfpt2 360518 1.51 glutamine-fructose-6-phosphate transaminase 2
Gk 79223 −0.63 glycerol kinase
Glrx 64045 0.66 glutaredoxin (thioltransferase)
Gria1 50592 −2.39 glutamate receptor, ionotropic, AMPA 1
Gstp1 24426 −0.53 glutathione S-transferase pi 1
Hap1 29430 −0.61 huntingtin-associated protein 1
Hdac4 363287 0.73 histone deacetylase 4
Hmgb1 25459 −0.84 high mobility group box 1
Hmgcra b d 25675 0.63 3-hydroxy-3-methylglutaryl-CoA reductase
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Table 2 Genes differentially expressed in ISIAH and WAG adrenal glands and referred to in Rat Genome Database as associated with
metabolic diseases (Continued)
Hmox1a 24451 −0.69 heme oxygenase (decycling) 1
Hpa b c d 24464 1.10 haptoglobin
Hsd11b2 25117 −1.47 hydroxysteroid 11-beta dehydrogenase 2
Hspa1a 24472 0.70 heat shock 70kD protein 1A
Hyal1 367166 0.49 hyaluronoglucosaminidase 1
Ifih1 499801 0.69 interferon induced with helicase C domain 1
Igf1 24482 −2.12 insulin-like growth factor 1
Il1r1 25663 0.86 interleukin 1 receptor, type I
Iscu 288740 −0.65 iron-sulfur cluster scaffold homolog (E, coli)
Isg15 298693 0.95 ISG15 ubiquitin-like modifier
Itga2 170921 −1.29 integrin, alpha 2
Itgava c 296456 −0.58 integrin, alpha V
Jak2c 24514 −0.63 Janus kinase 2
Jak3 25326 −0.57 Janus kinase 3
Jam3 315509 0.58 junctional adhesion molecule 3
Kcnma1 83731 0.77 potassium large conductance calcium-activated
channel, subfamily M, alpha member 1
Lcat d 24530 0.97 lecithin cholesterol acyltransferase
Ldlr b d e 300438 0.93 low density lipoprotein receptor
LOC689064 689064 2.02 beta-globin
Loxl1 315714 0.50 lysyl oxidase-like 1
Lpla d e 24539 0.52 lipoprotein lipase
Lrrk2 300160 1.12 leucine-rich repeat kinase 2
Lyz2 25211 0.80 lysozyme 2
Mgp 25333 0.48 matrix Gla protein
Mpo 303413 4.46 myeloperoxidase
Mpz 24564 1.69 myelin protein zero
Mt2A 689415 −1.05 metallothionein 2A
Myeov2 681389 −0.53 myeloma overexpressed 2
Myo5b 25132 −1.13 myosin Vb
Ndufaf2 361894 −0.85 NADH dehydrogenase (ubiquinone)
1 alpha subcomplex, assembly factor 2
Nefh 24587 1.44 neurofilament, heavy polypeptide
Nefm 24588 −0.79 neurofilament, medium polypeptide
Nr1d1 252917 −0.57 nuclear receptor subfamily 1, group D, member 1
Nucb2 59295 −0.64 nucleobindin 2
Oxct1 690163 −0.86 3-oxoacid CoA transferase 1
P2ry2 29597 −1.31 purinergic receptor P2Y, G-protein coupled, 2
Pah 24616 −0.86 phenylalanine hydroxylase
Pck1c 362282 3.83 phosphoenolpyruvate carboxykinase 1 (soluble)
Pfkfb1 24638 1.58 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 1
Phgdh 58835 −1.93 phosphoglycerate dehydrogenase
Pik3r1a 25513 0.50 phosphoinositide-3-kinase, regulatory
subunit 1 (alpha)
Pla2g7a 301265 −0.97
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Table 2 Genes differentially expressed in ISIAH and WAG adrenal glands and referred to in Rat Genome Database as associated with
metabolic diseases (Continued)
phospholipase A2, group VII (platelet-activating
factor acetylhydrolase, plasma)
Plau d 25619 −0.78 plasminogen activator, urokinase
Plin1 25629 2.04 perilipin 1
Postn 361945 1.30 periostin, osteoblast specific factor
Pparda 25682 0.56 peroxisome proliferator-activated receptor delta
Pparga d 25664 1.01 peroxisome proliferator-activated receptor gamma
Ppt1 29411 0.48 palmitoyl-protein thioesterase 1
Prkcba c 25023 0.90 protein kinase C, beta
Psmb9 24967 0.47 proteasome (prosome, macropain) subunit,
beta type 9 (large multifunctional peptidase 2)
Ptprn 116660 −0.75 protein tyrosine phosphatase, receptor type, N
Rbp4 25703 1.83 retinol binding protein 4, plasma
Retna 246250 2.26 resistin
RGD1562200 363471 0.84 patatin-like phospholipase
domain-containing protein 4-like
RT1-Ba c 309621 0.49 RT1 class II, locus Ba
RT1-Da 294269 0.80 RT1 class II, locus Da
RT1-Db1 294270 0.91 RT1 class II, locus Db1
S100b 25742 −1.72 S100 calcium binding protein B
Scd1 246074 2.16 stearoyl-Coenzyme A desaturase 1
Scn1b 29686 −0.56 sodium channel, voltage-gated, type I, beta
Serpina1a 24648 0.77 serpin peptidase inhibitor, clade A (alpha-1 antiproteinase,
antitrypsin, member 1
Serpine1a 24617 −2.04 serpin peptidase inhibitor, clade E (nexin, plasminogen
activator inhibitor type 1), member 1
Slc11a1 316519 0.69 solute carrier family 11 (proton-coupled divalent
metal ion transporters), member 1
Slc16a12 309525 0.91 solute carrier family 16, member 12
(monocarboxylic acid transporter 12)
Slc4a4 84484 0.96 solute carrier family 4, sodium bicarbonate
cotransporter, member 4
Slc7a7 83509 −0.69 solute carrier family 7 (amino acid transporter
light chain, y%2BL system), member 7
Slc8a1 29715 0.58 solute carrier family 8 (sodium/calcium exchanger), member 1
Slc9a3 24784 4.24 solute carrier family 9 (sodium/hydrogen exchanger), member 3
Sod2 24787 0.75 superoxide dismutase 2, mitochondrial
Sorbs1a 686098 −0.85 sorbin and SH3 domain containing 1
Spg11 311372 −0.55 spastic paraplegia 11 (autosomal recessive)
Spp1 25353 −0.56 secreted phosphoprotein 1
Stat5b 25126 −0.50 signal transducer and activator of transcription 5B
Tap1 24811 0.84 transporter 1, ATP-binding cassette, sub-family B (MDR/TAP)
Thbs1 445442 0.64 thrombospondin 1
Tnc 116640 1.74 tenascin C
Trpc6 89823 0.85 transient receptor potential cation channel, subfamily C, member 6
Ttr 24856 3.93 transthyretin
Uchl5 360853 −0.57 ubiquitin carboxyl-terminal hydrolase L5
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factor receptor signaling pathway, oxidation reduction,
calcium ion homeostasis, regulation of neurological sys-
tem process (regulation of synaptic plasticity).
Multiple DEGs were related to transport (transport of
lipids, cholesterol, and carboxylic acid) and regulation of
transport. The differences of adrenal gland functioning
in hypertensive ISIAH and normotensive WAG rats
were also found to be under control of many genes in-
volved in homeostatic process, lipid metabolic process,
intracellular signaling cascade, cell adhesion and extra-
cellular matrix organization, endocytosis, apoptosis, and
the regulation of these biological processes.
The immune system process and its regulation were
also among the most abundant and significantly
enriched groups. Multiple DEGs were associated with
inflammatory and adaptive, innate, and humoral im-
mune responses.
Among the 15 significantly enriched (p < 0.05) KEGG
(Kyoto Encyclopedia of Genes and Genomes) pathways
identified in the current study, there were several associ-
ated with the function of immune system (Additional file
7). The other were related to complement and the blood
coagulation cascades, PPAR signaling pathway, ECM-
receptor interaction, focal adhesion, chemokine signaling
pathway, glutathione metabolism. All of these pathways
contained genes associated with hypertension and meta-
bolic diseases.
The partial-least squares discriminant analysis (PLS-
DA) was performed to identify the genes making the
greatest impact to inter-strain differences. The con-
structed PLS-DA Axes maximized the distances between
rats from two strains (Fig. 2), and the Pearson correl-
ation calculated between gene expression and PLS-DA
Axis 1 helped to determine the distribution of the genes
along the axis representing the correlation between gene
expression and PLS-DA Axis 1 (Fig. 3). The DEGs are
shown in red in Fig. 3, and their polar position in the
histogram assumes their contribution to the inter-strain
differences. The 10 DEGs at the most polar position,
which are known as associated with hypertension and
showing greater than 2 fold differences in their level of
transcription in the adrenal glands of ISIAH and WAG
rats, were considered as the DEGs contributing the most
to the inter-strain variations (Table 4). The differential
transcription of these top 10 DEGs was validated by
qPCR (Fig. 4). The comparison of the relative mRNA
abundance between the RNA-Seq and qPCR measure-
ments is represented in Additional file 8. The results ob-
tained from the two methods were highly similar, with a
calculated correlation coefficient of 0.99.
Discussion
The transcriptome profiling of the adrenal glands from
ISIAH and WAG rats let to identify multiple DEGs and
several pathways contributing to differences between the
adrenal gland functions in ISIAH rats with stress-
sensitive hypertension and normotensive controls.
The study revealed several genes with detected tran-
scription in adrenal gland of only one rat strain. Three
of them (Crp, Fabp1, and Ucp1), known as associated
with hypertension, were expressed only in adrenal glands
from hypertensive rats. However, the low levels of ex-
pression of these genes were reported in adrenals from
normotensive Fischer 344 male rats, too [11]. So, the
inter-strain differences in transcriptional activity of these
genes shouldn’t be essential for hypertension develop-
ment in ISIAH rats.
The specificity of the stress-sensitive hypertension
may be seen from the functional annotation of DEGs
performed in Database for Annotation, Visualization
and Integrated Discovery (DAVID). The analysis
showed that the group of DEGs described by GO
term ‘response to stimulus’ was one of the most
abundant. This could be a priori expected for the
stress-induced models of hypertension, as the adrenal
gland is a component of the HPA and sympathetic-
adrenal medullary axes, which are both involved in
neuroendocrine response to stress [12, 13]. However,
in the current experiment, the rats were studied at
rest condition. So, we may suggest that among the
DEGs related to response to stimulus there should be
those particular ones which define the predominant
Table 2 Genes differentially expressed in ISIAH and WAG adrenal glands and referred to in Rat Genome Database as associated with
metabolic diseases (Continued)
Ucp1a 24860 detected only in ISIAH rats uncoupling protein 1 (mitochondrial, proton carrier)
Unc13a 64829 −1.01 unc-13 homolog A (C, elegans)
Vcam1a d 25361 0.78 vascular cell adhesion molecule 1
Vip 117064 −1.57 vasoactive intestinal peptide
Vldlr b d 25696 −0.61 very low density lipoprotein receptor
Wfs1 83725 1.77 Wolfram syndrome 1 homolog (human)
Xdh 497811 −0.88 xanthine dehydrogenase
Genes associated with: a-insulin resistance; b - hypercholesterolemia; c - hyperglycemia; d -hyperlipidemia; e - hyperlipoproteinemias; ISIAH and WAG – rat strains
used in the study
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Table 3 Transcription factor genes differentially expressed in ISIAH and WAG adrenal glands
Gene symbol Gene_ID log2 (fold_change) ISIAH/WAG Gene definition
Ajuba 85265 1.22 ajuba LIM protein
Apbb1 29722 0.52 amyloid beta (A4) precursor protein-binding,
family B, member 1 (Fe65)
Arhgap5 299012 −0.58 Rho GTPase activating protein 5
Bcl6 303836 −1.16 B-cell CLL/lymphoma 6
Cbfb 361391 −0.66 core-binding factor, beta subunit
Ccnc 114839 −0.59 cyclin C
Ccnl2 298686 −0.72 cyclin L2
Cebpa 24252 0.85 CCAAT/enhancer binding protein (C/EBP), alpha
Cnot3 308311 0.60 CCR4-NOT transcription complex, subunit 3
Creb3l1 362165 1.22 cAMP responsive element binding protein 3-like 1
Csrp2 29317 −0.60 cysteine and glycine-rich protein 2
Dab2 79128 0.79 disabled homolog 2 (Drosophila)
Egr1a 24330 −0.92 early growth response 1
Ets2 304063 −0.83 v-ets erythroblastosis virus E26
oncogene homolog 2 (avian)
Etv1 362733 −0.52 ets variant 1
Fev 246271 −0.92 FEV (ETS oncogene family)
Foxo1b 84482 −0.86 forkhead box O1
Fus 317385 0.65 fused in sarcoma
Grhl1 313993 1.06 grainyhead-like 1 (Drosophila)
Hcls1 288077 0.63 hematopoietic cell specific Lyn substrate 1
Hdac4a 363287 0.73 histone deacetylase 4
Hes1 29577 −0.84 hairy and enhancer of split 1 (Drosophila)
Hltf 295568 −0.58 helicase-like transcription factor
Ifi204 304988 1.05 interferon activated gene 204
Irf7 293624 1.64 interferon regulatory factor 7
Irf9 305896 0.77 interferon regulatory factor 9
Junb 24517 −1.58 jun B proto-oncogene
Klhl6 287974 1.00 kelch-like family member 6
Lcor 365462 −0.59 ligand dependent nuclear receptor corepressor
Ldb3 498587 1.30 LIM domain binding 3
Mbd1 291439 −0.81 methyl-CpG binding domain protein 1
Mcm7 288532 0.80 minichromosome maintenance complex component 7
Mlxipl 171078 −0.93 MLX interacting protein-like
Mphosph8 290270 −0.86 M-phase phosphoprotein 8
Nfkbil1 361794 0.62 nuclear factor of kappa light polypeptide gene
enhancer in B-cells inhibitor-like 1
Nfx1 313166 0.50 nuclear transcription factor, X-box binding 1
Nkx3-1 305999 2.11 NK3 homeobox 1
Nr1d1 252917 −0.57 nuclear receptor subfamily 1, group D, member 1
Nr4a3 58853 1.20 nuclear receptor subfamily 4, group A, member 3
Nrip1 304157 −0.70 nuclear receptor interacting protein 1
Pcaf 301164 −0.54 p300/CBP-associated factor
Pdlim3 114108 1.06 PDZ and LIM domain 3
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activation of the HPA and the sympathetic adrenal
medullary axes in the pathogenesis of the hyperten-
sive state in ISIAH rats selected for the enhanced BP
in response to the mild emotional stress (0.5 h re-
striction in a small wire mesh cage) [7, 9].
Earlier in the study of the adrenal medulla transcrip-
tome in Sprague-Dawley rats it was reported that mul-
tiple transcription factors were upregulated in response
to the acute immobilization stress [5]. In the current ex-
periment, the group of DEGs, associated with the GO
Fig. 1 The main Gene Ontology (GO) terms for biological processes. Numerals represent the number of genes in the group
Table 3 Transcription factor genes differentially expressed in ISIAH and WAG adrenal glands (Continued)
Pml 315713 0.54 promyelocytic leukemia
Ppardb 25682 0.56 peroxisome proliferator-activated receptor delta
Pparga b 25664 1.01 peroxisome proliferator-activated receptor gamma
Preb 58842 0.52 prolactin regulatory element binding
Pric285 296474 0.50 peroxisomal proliferator-activated receptor A
interacting complex 285
Prpf4b 291078 −0.58 PRP4 pre-mRNA processing factor 4 homolog B (yeast)
Rbm43 311020 0.80 RNA-binding protein 43
Rere 116665 −0.57 arginine-glutamic acid dipeptide (RE) repeats
Smurf2 303614 0.95 SMAD specific E3 ubiquitin protein ligase 2
Stat5b 25126 −0.50 signal transducer and activator of transcription 5B
Tcf3 171046 0.67 transcription factor 3
Tfdp2 300947 −0.78 transcription factor Dp-2 (E2F dimerization partner 2)
Tgfb1i1 84574 1.11 transforming growth factor beta 1 induced transcript 1
Twist2 59327 1.00 twist homolog 2 (Drosophila)
Vgll3 498038 1.66 vestigial-like family member 3
Zbtb16 353227 1.26 zinc finger and BTB domain containing 16
Zfp281 305083 −0.54 zinc finger protein 281
Zfp292 50552 −0.53 zinc finger protein 292
Zmynd12 313552 −0.96 zinc finger, MYND-type containing 12
Genes associated with: a- hypertension; b - insulin resistance; ISIAH and WAG – rat strains used in the study
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term ‘response to stimulus’ in ISIAH rats, also contained
multiple transcription factor genes most of which (13 out
of 21) were upregulated. In the experiment with gene
transcriptional profiling after acute immobilization stress
in the adrenal medulla from the Sprague-Dawley rats [5]
and in the current study we found 4 common transcrip-
tion factor genes (Egr1, Junb, Nr4a3, and Ppard), with
Nr4a3 and Ppard being upregulated in both experiments.
The orphan nuclear receptor, NOR-1 (also known as
NR4A3) was reported as a target of beta-adrenergic sig-
naling in skeletal muscles [14]. Taking all the information
together, we may hypothesize that the enhanced transcrip-
tional activity of Nr4a3 may be related to the predominant
activation of the sympathetic-adrenal medullary axis in
ISIAH rats. To our knowledge, the role of the sympathetic
nervous system in activation of Ppard has not been de-
scribed up to date, however, its important role may be ex-
pected from the study of the acute immobilization stress
response of the adrenal glands in Sprague-Dawley rats [5].
The adrenal medullary tissue contributes to maintain
body homeostasis in stressful environment via the re-
lease of catecholamines into circulatory system in re-
sponse to splanchnic nerve activation [15]. The
acetylcholine released by the sympathetic splanchnic
nerves activates neuronal-type nicotinic acetylcholine re-
ceptors (nAChRs) on the membrane of chromaffin cells
Fig. 3 The correlation between genes expression and PLS-DA Axis 1. DEGs distribution is shown in red
Fig. 2 Axes maximizing the distances between ISIAH and WAG rats
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which liberate catecholamines into the bloodstream in
preparation for the fight and flight reactions [16]. In the
current study several DEGs involved in the regulation of
catecholamine secretion were found (Additional file 6),
including Chrna4 (cholinergic receptor, nicotinic, alpha
4). However, Chrna4 was downregulated in ISIAH adre-
nals. Besides, one more gene in this group, Cartpt
(CART prepropeptide) known as activating sympathoa-
drenal outflow [17], was also decreased. These findings
suggest the involvement of the Chrna4 and Cartpt genes
in compensatory mechanism directed to attenuate the
catecholamine release by the adrenals of ISIAH rats.
The predominantly increased effectiveness of the HPA
axis in the ISIAH rats may be related to the DEGs par-
ticipating in response to hormonal stimuli. Most of the
DEGs in this group (16 out of 25) were upregulated in
the adrenal glands from ISIAH rats (Additional file 6),
and about half of them are known as associated with
hypertension. Three of these DEGs (Avpr1a, arginine
vasopressin receptor 1A; Hsd11b2, hydroxysteroid 11-
beta dehydrogenase 2; and Igf1, insulin-like growth fac-
tor 1) were reckoned among the top 10 DEGs making
the most significant contribution to the inter-strain dif-
ferences (Table 4).
V1a receptor (Avpr1a) plays an important role in the
basal arterial BP maintenance by regulation of circulat-
ing blood volume and baroreflex sensitivity [18]. Vaso-
pressin is a potent autocrine/paracrine regulator of
mammal adrenal functions. V1a receptor is expressed
both in adrenal cortex and adrenal medulla. In the ad-
renal cortex V1a receptor triggers both steroid secretion
and cortical growth [19]. Besides, V1a receptor is present
in vascular smooth muscles and is responsible for the
classical vasopressor action of vasopressin [20]. The
Avpr1a upregulation in the ISIAH adrenal glands may
indicate the exaggerated effects on multiple adrenal
functions in ISIAH rats.
Our previous studies confirmed the reduced activity of
11β-hydroxysteroid dehydrogenase type 2 (11β-HSD2)
in adrenal glands of ISIAH rats [21] and in peripheral
blood plasma [10]. It was shown that the loss-of-
function mutations or inhibition of 11β-HSD2 results in
overstimulation of the mineralocorticoid receptor by
glucocorticoids and causes salt-sensitive hypertension
Fig. 4 The relative mRNA abundance measured by qPCR. The significance of inter-strain difference is indicated by *p < 0.05,
**p < 0.01, ***p < 0.001
Table 4 The top 10 DEGs making the most significant contribution to the inter-strain differences and associated with hypertension
Gene symbol Gene_ID log2
(fold_change) ISIAH/WAG
Gene definition
Agt 24179 2.28 angiotensinogen (serpin peptidase inhibitor, clade A, member 8)
Avpr1a 25107 1.12 arginine vasopressin receptor 1A
Ephx2 65030 4.37 epoxide hydrolase 2, cytoplasmic
Gabbr1 81657 1.11 gamma-aminobutyric acid (GABA) B receptor 1
Hsd11b2 25117 −1.47 hydroxysteroid 11-beta dehydrogenase 2
Igf1 24482 −2.12 insulin-like growth factor 1
Mpo 303413 4.46 myeloperoxidase
S100b 25742 −1.72 S100 calcium binding protein B
Serpine1 24617 −2.04 serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
Serpine2 29366 2.19 serpin peptidase inhibitor, clade E, member 2
ISIAH and WAG – rat strains used in the study
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[22]. Taking into account the decreased level of Hsd11b2
transcription and its protein activity in adrenal glands
and other tissues of ISIAH rats, which resulted in de-
crease of 11-dehydrocorticosterone/corticosterone ratio
in peripheral blood plasma, we may suggest the import-
ance of this mechanism in stress-sensitive hypertension
development, too.
The decreased transcription of Igf1 in ISIAH adrenals
is in a good agreement with the observation that IGF1
expression may be significantly decreased in the pres-
ence of hypertension [23]. An increase in the IGF1 pro-
duction was reported in rats undergoing the
compensatory growth of the adrenal gland following the
unilateral adrenalectomy [24]. As the weight of the ad-
renal glands is significantly higher in ISIAH rats as com-
pared to WAG rats [25], we suggest that the decreased
transcription of Igf1 in ISIAH adrenals may be adaptive.
The data of the current study revealed also many other
DEGs associated with hypertension and metabolic dis-
eases, the main feature of which is insulin resistance.
Adrenocortical dysregulation is considered as a major
player in insulin resistance and onset of obesity [26]. It
is believed that insulin resistance is directly correlated
with the severity of hypertension [27] and may account
for the etiology of essential hypertension in as many as
half of the patients with the disease [28]. In the current
study, three DEGs associated with both hypertension
and insulin resistance (Agt, angiotensinogen; Ephx2, ep-
oxide hydrolase 2; and Serpine1, serpin peptidase inhibi-
tor, clade E (nexin, plasminogen activator inhibitor type
1), member 1) were put on the list of the top 10 DEGs
making the most significant contribution to the inter-
strain differences (Table 4).
Angiotensinogen is the substrate of renin and the pre-
cursor of the angiotensin peptides having the powerful
vasoconstrictive properties. The activation of renin-
angiotensin system (RAS) is considered not only as a
main hypertensive system, but also as a key factor trig-
gering reactive oxygen species production, oxidative
stress, endothelial dysfunction and hypertension devel-
opment [29]. The elevated transcription of the Agt gene
in ISIAH adrenal glands points out the involvement of
the adrenal tissue RAS in the development of stress-
sensitive hypertension. However, our data differ from
those previously reported for spontaneously hypertensive
rats (SHR). It was shown that adrenal angiotensinogen
mRNAs were lower in SHR than in control WKY rats at
14 weeks of age [30]. This discrepancy is probably one
of the features distinguishing the mechanism of hyper-
tension development in ISIAH rats from that in SHRs.
Ephx2 encodes the soluble epoxide hydrolase (sEH)
that metabolizes the epoxyeicosatrienoic acids, which
produce vasorelaxation and exert anti-inflammatory and
pro-fibrinolytic effects [31]. sEH was linked to
hypertension in the studies on different animal models
of the disease: spontaneous [32], angiotensin II-induced
[33], and programmed hypertension [34]. Soluble epox-
ide hydrolase deficiency improves glucose homeostasis
in a model of insulin resistance [35]. Taking into account
the above information, we may suggest that Ephx2 acti-
vation may contribute to disease development in ISIAH
rats.
The plasminogen activator inhibitor 1 (PAI1 or SER-
PINE1), known as coagulation marker, has been found
to correlate with all components of the insulin resistance
syndrome, and can be considered as a true component
of the metabolic syndrome [36]. Increased plasma PAI1
may be involved in the occurrence of micro-vascular
complications and increased risk of atherosclerosis [37].
The inhibition of PAI1 results in reduction of cell adhe-
sion and cellular proliferation, particularly in reduction
of angiogenesis [38]. So, decreased transcription of the
Serpine1 in ISIAH adrenals may work against the exces-
sive development of angiogenesis and micro-vascular
complications in stress-sensitive hypertension.
As long as the PLS regression method is commonly
used for biomarker selection in metabolomic [39] and
gene expression [40] studies, the other DEGs listed in
the Table 4 (Gabbr1, gamma-aminobutyric acid B recep-
tor 1; Mpo, myeloperoxidase; S100b, S100 calcium bind-
ing protein B; and Serpine2, serpin peptidase inhibitor,
clade E, member 2) may also be indicated as deserving a
high priority in future investigations of molecular mech-
anisms of the stress-sensitive hypertension. Their pos-
sible contribution to the disease development in ISIAH
rats is discussed below.
Metabotropic GABAB receptors (GABABRs) abun-
dantly expressed at inhibitory and excitatory synapses
are mostly studied in the brain, where they play an im-
portant role in modulating synaptic transmission by
their presynaptic inhibitory effects on calcium channels
and postsynaptic activating effects on potassium chan-
nels [41, 42]. It was also shown that activation of
GABABRs protects neurons from apoptosis via IGF1 re-
ceptor transactivation [43]. However, gamma-
aminobutyric acid (GABA) is produced not only in the
brain, but also in endocrine cells including rat adrenal
medullary chromaffin cells. Since there are no GABAer-
gic nerve fibers in the adrenal medulla, GABA may func-
tion as a para/autocrine factor [44]. The functional role
of the elevated transcription of Gabbr1 in adrenal glands
is not known and has to be studied, as it might be essen-
tial for stress-sensitive hypertension development in
ISIAH rats.
Myeloperoxidase (MPO) delays neutrophil apoptosis
and prolongs inflammation [45]. The activation of MPO
may contribute to the development of obesity and
obesity-associated insulin resistance [46]. So, it may be
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expected that the elevated Mpo transcription found in
ISIAH adrenals in the current study may contribute to
insulin resistance and inflammation in ISIAH rats, too.
S100b expression is studied mostly in the central ner-
vous system, where the role of S100 beta is related to
the development and maintenance of neuronal function
[47]. S100 beta may influence the cell survival in a
concentration-dependent manner [48]. Recently, it was
reported that the decreased expression of S100 beta may
be associated with the neuroprotective mechanism
against acute stress [49]. So, the role of the S100b de-
creased transcription in adrenal glands of ISIAH rats
may be associated with the sympathetic nervous system
regulation of the stress-sensitivity in ISIAH rats.
Serpine2 encodes serine (or cysteine) proteinase inhibi-
tor, clade E, member 2 (or protease nexin1, PN-1) which
is associated with the negative regulation of blood co-
agulation [50, 51].
As it is seen from the above discussion, the top 10
DEGs making the most significant contribution to the
inter-strain differences (Table 4) possess different func-
tional properties and may contribute to many physio-
logical mechanisms possibly related to hypertension
development in ISIAH rats. Four of these DEGs (Agt,
Avpr1a, Ephx2, and Hsd11b2) were related to GO term
group 'regulation of BP'. Among the other members of
this group there was the transcription factor Pparg.
The pathway enrichment analysis in KEGG database
showed that the PPAR (peroxisome proliferator-
activated receptor) signaling pathway was among the
most significantly enriched in the current study. The
DEGs related to this pathway were mostly upregulated
in ISIAH adrenal glands (Additional file 7). Among the
upregulated DEGs there were 6 genes associated with
hypertension, including the Adipoq and Lpl genes en-
coding adiponectin and lipoprotein lipase, which are rec-
ognized as an indicators for PPAR-gamma activation
[52–54]. In the current study two genes (Ppard and
Pparg) encoding the members of the PPAR subfamily of
nuclear receptors were upregulated.
The physiological role of PPARs is related to lipid me-
tabolism and energy homeostasis [53]. PPAR-gamma has
been implicated in the pathology of numerous diseases
including insulin resistance, diabetes, atherosclerosis and
hypertension [55, 56]. PPAR-gamma activation attenu-
ates insulin resistance and inflammation [57, 58]. PPAR-
delta activation ameliorates obesity and insulin resist-
ance [59], and has been considered as a potential thera-
peutic target in treatment of lipid-related disorders,
including dyslipidemia and diabetes [60, 61].
Earlier it was shown that the hypertension develop-
ment in ISIAH rats is accompanied by dislipidemia, in-
creased glucose content, increased body weight, and
enhanced DNA-binding activity of several transcription
factors including PPARs in liver. These data suggested
the development of metabolic syndrome in ISIAH rats
[62]. Probably, the elevated transcription of Pparg and
Ppard in the adrenal gland of ISIAH rats plays adaptive
role and is directed to the attenuation of the processes
leading to the metabolic syndrome development.
Both GO and KEGG analyses indicated the high im-
pact of the immune system processes on the formation
of the interstrain differences in ISIAH and WAG rats
(Fig. 1 and Additional file 7). Multiple DEGs associated
with GO term ‘immune system process’ are annotated in
RGD as associated with hypertension. The important
role of inflammation and immunity in development of
the stress-sensitive hypertension was already highlighted
in our previous comparative studies of genome-wide
transcriptome analyses of hypothalamus and renal cortex
from ISIAH and WAG rats [63, 64]. A growing body of
research supporting a role of inflammation and immun-
ity in hypertension was recently summarized in multiple
reviews [65–72]. Many of the authors reviewing the
problem consider that cells of both the innate and adap-
tive immune system contribute to end-organ damage
and dysfunction in hypertension, and the molecular de-
terminants of the immune cells activation may be a pu-
tative therapeutic targets to reduce end-organ damage
and prevent pathological consequences of hypertension
[68, 69, 73]. The results of our study are in a good agree-
ment with these opinions and may be useful to define
the common molecular determinants, which may be rec-
ognized as potential targets for therapy and prevention
of hypertensive disease.
Conclusion
Recently, the molecular studies of the pathogenesis of
genetic hypertension strongly highlighted the complex
nature of the disease. The current study of the compara-
tive transcriptional profiling of the adrenal glands in
ISIAH rats with the stress-sensitive arterial hypertension
and control WAG rats resulted in detection of multiple
DEGs related to different endocrine, inflammatory,
neural, and metabolic processes and pathways. The dis-
cussion of the results helped to prioritize the following
genes.
Two transcription factor genes (Nr4a3 and Ppard)
were found to be common and upregulated both in ad-
renal of ISIAH rats and in the adrenal medulla from the
Sprague-Dawley rats after acute immobilization stress.
We suggest that the upregulation of these genes may be
related to the predominant activation of the
sympathetic-adrenal medullary axis in ISIAH rats; how-
ever, their real contribution to the hypertensive pheno-
type remains to be demonstrated.
The use of the PLS-DA helped to reveal a number of
DEGs making the most significant contribution to the
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inter-strain differences. The discussion of ten of them
known as associated with hypertension demonstrated
that four of these genes (Avpr1a, Hsd11b2, Agt, Ephx2)
may provoke the hypertension development, and Mpo
may contribute to insulin resistance and inflammation in
ISIAH rats. These DEGs may be considered as the most
promising candidates for further studies of the mecha-
nisms underlying the stress-sensitive hypertension
development.
It was not possible to discuss the functional roles for
all the DEGs found in the current study. The differential
expression of the genes not necessary must be related to
hypertensive phenotype. So, the attention was mostly
paid to the discussion of the DEGs already known as as-
sociated with hypertension, which could be considered
as the most potentially interesting candidates for further
studies of the mechanisms underlying the stress-
sensitive hypertension development. However, the list of
genes associated with hypertension is permanently
expanding. Thus, we can’t exclude that the other genes
found to be differentially expressed in ISIAH and WAG
adrenal glands may also influence the development of
hypertensive phenotype.
The results of the current study may be useful to identify
the common molecular determinants in different animal
models of arterial hypertension and to define the potential
targets for therapy and prevention of hypertensive disease.
Methods
Animals
The study was performed using the hypertensive ISIAH/
Icgn and normotensive WAG/GSto-Icgn rat strains. The
rats from both strains were bred in the Center for Genetic
Resources of Laboratory Animals at the Institute of Cy-
tology and Genetics, SB RAS, Novosibirsk, Russia (Identi-
fication numbers in the list of National Animal Facilities
of Russia RFMEFI61914X0005 and RFMEFI62114X0010).
The ISIAH rat strain (Inherited Stress-Induced Arter-
ial Hypertension) is a rat model with the genetically de-
termined exaggerated sensitivity to stressful stimuli [9].
The ISIAH rats were selected for a strong elevation of
the systolic arterial blood pressure (SABP) in response
to a brief emotional stress. To cause the emotional stress
the animal was kept for 30 min in a small cylindrical
wire mesh cage [7, 8]. This procedure leads to 20–
25 mmHg elevation of SABP in ISIAH rats and doesn’t
cause the significant changes of SABP in WAG rats used
as a normotensive control. Both ISIAH and WAG rat
strains derived from outbred Wistar rats. The process of
ISIAH rat strain selection for the dramatic increase of
SABP during mild emotional stress was accompanied by
the elevation of the SABP at rest condition, which is
about 175.0 ± 3.5 mmHg in males and 165.0 ± 3.0 mmHg
in females from the current population. The high degree
of genetic homogeneity of the ISIAH strain was con-
firmed by the DNA fingerprinting approach [74].
All rats were kept under the standard environmental
conditions with ad libitum access to food and water. An-
imals were individually caged a week before the SABP
measurement, which was done indirectly by the tail-cuff
method with the use of short-term ether anesthesia. The
preliminary work showed that the blood pressure mea-
sured in the ether anesthetized rats is close to the mea-
sures made in the unanesthetized rats after many days of
adaptation to the procedure of indirect tail-cuff method
as well as to the blood pressure levels measured in the
home-cage drectly trough indwelling arterial catheter.
The RNA-Seq experiments were conducted on ISIAH
and WAG males aged 3-month old. Each experimental
group consisted of three rats. Their SABP was 171.7 ±
1.2 mmHg and 116.3 ± 1.9 mmHg in ISIAH and WAG
males, correspondingly. Six days after SABP measure-
ment, rats were decapitated, and their left adrenal glands
were immediately removed and stored in RNA Later
(Qiagen, Chatsworth, CA) at −70 °C. The relative
amount of target mRNA was measured by semi-
quantitative real-time PCR (qPCR) in the left adrenal
glands from 3-month old ISIAH and WAG male rats.
Each group consisted of seven rats. Their SABP was
measured as described above. It was 174.3 ± 1.3 mmHg
in ISIAH and 122.1 ± 1.8 mmHg in WAG rats. The rats
were also decapitated 6 days after measurement of SABP,
and their left adrenal glands were rapidly removed, fro-
zen and stored at −70 °C until use.
The animal experiments protocols received approval
of the Institute’s Animal Care and Use Committee.
RNA-Seq analysis
The technological part of the RNA-seq analysis was per-
formed in JSC Genoanalytica (Moscow, Russia). The
mRNA from the samples of agrenal glands was extracted
using Dynabeads mRNA Purification Kit (Ambion,
USA). NEBNext mRNA Library Prep Reagent Set for
Illumina (NEB, USA) was used to construct the cDNA
libraries following the manufacturer’s protocol. The
single-end sequencing of the cDNA libraries was carried
out on Illumina HiSeq1500 Sequencing System (Illumina
Sequencing, San Diego, USA) with read length of 50
bases. All samples were run as biological replicates. The
sequencing data after adapter trimming and low-quality
sequence removal were mapped to the RGSC
Rnor_5.0\rn5 reference genome with the use of Tophat2
aligner [75]. CollectRnaSeqMetrics from the Picard tools
suit (http://broadinstitute.github.io/picard/) was used to
collect the quality metrics of the mapped data (Add-
itional file 9). The Cufflinks program was employed to
count gene expression levels in FPKM (fragments per
kilobase of transcript per million mapped reads). Gene
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annotation was based on NCBI Gene/RefSeq database.
A gene was defined as being expressed if it has success-
fully passed the Cufflinks statistical testing and was
assigned to test status ‘OK’. Cuffdiff was used to identify
the genes with differential expression under a false dis-
covery rate (FDR) threshold of 0.05 [76]. The RNA-Seq
data were deposited in the NCBI SRA database under
the Accession number: PRJNA299102.
Functional annotation
The DAVID (The Database for Annotation, Visualization
and Integrated Discovery) tool (http://david.abcc.ncifcrf.-
gov/) was employed for functional annotation of DEGs
[77, 78]. The Rattus norvegicus genome was utilized as
the background list for the over-representation analysis.
The Gene Ontology option was used to identify the sig-
nificantly (p < 0.05) enriched biological processes. The
Kyoto Encyclopedia of Genes and Genomes (KEGG,
http://www.genome.jp/kegg/) Pathway Database was
used to identify the significantly (p < 0.05) enriched
metabolic pathways. The annotation of DEGs in Rat
Genome Database (RGD, http://rgd.mcw.edu/) helped to
reveal the genes associated with hypertension and meta-
bolic diseases. The DEGs were annotated in GenBank
(http://www.ncbi.nlm.nih.gov/gene/), an atlas of com-
binatorial transcriptional regulation in mouse and man
[79], and Panther classification system (http://
www.pantherdb.org/) [80] to reveal those encoding the
transcription factors.
qPCR
The extraction of the total RNA was carried out with
the use of the TRI reagent RNA isolation protocol (Mo-
lecular research center, USA), and the residual genomic
DNA was removed from the total RNA samples by
DNase I (Promega, USA) treatment, following the man-
ufacturer’s instructions.
The reaction mixture for reverse transcription con-
tained reverse transcription buffer (Vektor-Best, RF),
0.25 nmol of random nonanucleotide primers (Biosan,
RF), 0.4 mM dNTPs, 3 μg of RNA, and 40 units of
MoMLV (Vektor-Best, RF) in the total volume of 50 μl.
The protocol for cDNA synthesis was as follows: 1 h at
37 °C, 30 min at 42 °C, and 10 min at 50 °C. The enzyme
was inactivated by heating the reaction mixture during
5 min at 75 °C.
qPCR was carried out in a final volume of 20 μl con-
taining a master mix with SYBR Green, 0.15 mM of each
forward and reverse primers, the cDNA template, and 1
unit of HotStart Taq polymerase (Vektor-Best, RF). The
Ppia (peptidylprolyl isomerase A) was used as a refer-
ence gene. Primer sequences and their characteristics
are represented in Additional file 10.
The iCycler iQ4 Real-Time PCR Detection System
(Bio-Rad Laboratories, USA) was used to run qPCR. The
reaction was started at 94 °C for 1 min and followed by
40 cycles of 15 s at 94 °C, 20 s at primer’s annealing
temperatures listed in Additional file 10, 20 s at 72 °C,
and fluorescence signal acquisition (10 s). The melting
curve was generated in the range of 65 °C to 94 °C. Rela-
tive transcript levels were determined with the use of
standard-curve quantitation method [81]. The aliquots
from each of the synthesized cDNA samples were
pooled and used as the standard cDNA. The qPCR was
run using the same cDNA samples with primers for the
target gene and for the reference gene, which were
loaded onto the plate as four replicates per cDNA sam-
ple, and the standard cDNA dilutions (1 : 1, 1 : 4, 1 : 16,
and 1 : 64) with the primers for the target gene (two rep-
licates), and for the reference gene (two replicates)
loaded onto the same plate. iCycler iQ4 Real-Time PCR
Detection System software was used to build the calibra-
tion curves for calculation of the relative amount of
cDNAs.
The value for the target gene was normalized against the
value obtained for the reference gene. The relative mRNA
abundance was calculated as a ratio of the normalized
mRNA level calculated for the experimental ISIAH samples
to the normalized mRNA level obtained for the samples
from control WAG rats, which was set a value of 1.
Statistical methods
Statistical significance for qPCR data was calculated by
Student’s t-test. A p value < 0.05 was considered signifi-
cant. Data were expressed as means and standard errors
of means (M ± SEM).
The data (FPKM values) obtained from RNA-Seq were
log transformed, centered, and normalized. The principal
coordinates analysis based on Euclidean metric distances
was employed to scale the data sets, and PLS-DA was
used to construct the PLS-DA Axes maximizing the dis-
tances between ISIAH and WAG rats. Then, the Pearson
correlation was explored to determine a set of variables
(i.e. expressed genes) that maximize the covariance be-
tween gene expression in ISIAH and WAG rats and
fixed dummy matrix representing group membership
[82] for rats from different strains. These procedures
helped to define the genes showing the most deviation
along the axis representing the correlation between gene
expression and PLS-DA Axis 1, which were assumed as
genes contributing the most to inter-strain variations.
The Pearson correlation between mean values (repre-
sented as log2(fold_change)ISIAH/WAG) obtained by
RNA-Seq and qPCR for 10 genes (Agt, Avpr1a, Ephx2,
Gabbr1, Hsd11b2, Igf1, Mpo, S100b, Serpine1, Serpine2)
was used to count the correlation coefficient between
the results derived from these methods.
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